Modulation of taurine on CYP3A4 induction by rifampicin in a HepG2 cell line.
Takahashi
Kyoko
K
Clinical Evaluation of Medicine and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Matsuda
Hideyasu
H
Kinoshita
Kayoko
K
Matsunaga
Norikazu
N
Sumita
Akihiko
A
Matsuda
Takahisa
T
Takahashi
Koichi
K
Azuma
Junichi
J
D002460:Cell Line; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis* / Q000235:genetics; D004790:Enzyme Induction; D006801:Humans; D010634:Phenobarbital / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012293:Rifampin / Q000493:pharmacokinetics*; D013654:Taurine / Q000494:pharmacology*
D012333:RNA, Messenger; D013654:Taurine; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D012293:Rifampin; D010634:Phenobarbital